Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
GHK-Cu is the copper-bound form of the human tripeptide glycyl-L-histidyl-L-lysine, originally isolated by Pickart from human plasma albumin in 1973 [1]
Telehealth Consultation Consultation Cost $99 Your consultation may include: Provider evaluation Medical history review Treatment eligibility assessment Discussion of GLP-1 or peptide therapy options Personalized recommendations and next steps Blood work, if required, is not included
Targets fat cells Binds beta-3 adrenergic receptors found on adipocytes
Research has explored its influence on cellular signaling, angiogenesis, and musculoskeletal recovery, making it a subject of interest in various scientific studies
An asparagine converts to aspartate
What Patients Evaluating AOD 9604 Typically Report Timeline to first changes: Most published protocols note 4 to 6 weeks before body composition changes become measurable Areas of change: Visceral and subcutaneous fat reduction, with particular effect reported in the abdominal region in some subjects Energy and recovery: Some participants in clinical and investigational settings report improved energy and exercise recovery, though this is not a primary mechanism of the peptide What it is not: AOD 9604 does not cause rapid dramatic weight loss the way GLP-1 medications can in the first few months
US$ 25.60
US$ 22.72
US$ 29.06
US$ 25.10
US$ 29.08
